Right, from a private capital perspective, it's a misallocation of resources. If a company can make X% return on capital (researchers, equipment, marketing, re

Right, from a private capital perspective, it's a misallocation of resources. If a company can make X% return on capital (researchers, equipment, marketing, regulatory engagement, office space etc) working on communicable diseases, but Y% >> X% doing something else, a responsible steward of somebody else's pile of money is supposed to direct the capital towards Y.